
Omica Biomed is a veterinary oncology service provider offering a comprehensive suite of diagnostic solutions for canine and feline cancers. Their core offerings include liquid biopsy tests like OncoCan for tumor detection and monitoring, PARR for lymphoma/leukemia diagnosis, and genetic mutation analysis for genes like c-Kit and B-Raf. They also provide histopathology services for accurate tumor characterization and prognosis. Omica Biomed emphasizes innovation, scientific evidence, and integral service, leveraging advanced technologies such as NGS and AI, supported by a multidisciplinary team of experts. Their business model appears to be service-based, catering to veterinary professionals seeking advanced diagnostic tools to personalize patient care.

Omica Biomed is a veterinary oncology service provider offering a comprehensive suite of diagnostic solutions for canine and feline cancers. Their core offerings include liquid biopsy tests like OncoCan for tumor detection and monitoring, PARR for lymphoma/leukemia diagnosis, and genetic mutation analysis for genes like c-Kit and B-Raf. They also provide histopathology services for accurate tumor characterization and prognosis. Omica Biomed emphasizes innovation, scientific evidence, and integral service, leveraging advanced technologies such as NGS and AI, supported by a multidisciplinary team of experts. Their business model appears to be service-based, catering to veterinary professionals seeking advanced diagnostic tools to personalize patient care.